1. Home
  2. BW vs CDNA Comparison

BW vs CDNA Comparison

Compare BW & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Babcock & Wilcox Enterprises Inc.

BW

Babcock & Wilcox Enterprises Inc.

HOLD

Current Price

$8.84

Market Cap

919.9M

Sector

Industrials

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$18.81

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BW
CDNA
Founded
1867
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
919.9M
1.0B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
BW
CDNA
Price
$8.84
$18.81
Analyst Decision
Buy
Buy
Analyst Count
3
7
Target Price
$7.00
$27.33
AVG Volume (30 Days)
2.2M
622.2K
Earning Date
01-01-0001
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$48,324,000.00
Revenue This Year
N/A
$12.18
Revenue Next Year
$6.69
$10.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
18.93
52 Week Low
$0.22
$10.96
52 Week High
$11.57
$22.61

Technical Indicators

Market Signals
Indicator
BW
CDNA
Relative Strength Index (RSI) 47.58 44.67
Support Level $7.98 $18.30
Resistance Level $11.57 $20.74
Average True Range (ATR) 0.76 1.02
MACD -0.17 -0.13
Stochastic Oscillator 26.43 43.04

Price Performance

Historical Comparison
BW
CDNA

About BW Babcock & Wilcox Enterprises Inc.

Babcock & Wilcox Enterprises Inc is a power generation equipment supplier and servicing company that operates in three segments: B&W Renewable, B&W Environmental, and B&W Thermal. B&W Thermal, focuses on steam generation products and solutions for plants in the power generation, oil, and gas, and industrial sectors, generates the majority of the company's revenue. B&W Renewable focuses on sustainable power and heat generation while B&W Environmental focuses on emissions control. The company's customer base spans the industrial, electrical utility, and municipal industries located predominantly in the United States, Canada, Denmark, the United Kingdom, and other regions. Business in the U.S. contributes the vast majority of its revenue.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: